There is no commercial support for this activity.
Expiration Date: 7/14/2020
This educational activity will utilize a case study to discuss the diagnosis and management of a 45-year-old woman with hypercholesterolemia and a family history of…go to activity»
This activity is supported by educational funding provided by The Medicines Company.
Expiration Date: 6/26/2020
Did you miss the National Lipid Association’s 2019 Scientific Sessions? You can now view this special recorded session to learn from our experts about the future beyond…go to activity»
This activity is sponsored as an educational service by Actelion Pharmaceuticals US, Inc. The information herein is not intended for continuing medical education (CME) purposes.
June 14, 2019
Risk assessment can be used not only to determine prognosis, but also to identify treatment goals and monitor disease progression, and to evaluate treatment…go to activity»
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Expiration Date: 3/3/2020
This activity will address the management of heart failure (HF) in older adults, African Americans, patients with diabetes, and patients with poor renal function
.go to activity»
This activity is sponsored by
Janssen Pharmaceuticals, Inc. The information contained herein is not intended for continuing medical education (CME) purposes.
April 25, 2019
This activity examines a treatment that may reduce CV events, A1C levels, and systolic BP for patients with type 2 diabetes
.go to activity»
Supported in part by Aegerion, Inc. and REGENXBIO Inc.
April 8, 2019
The National Lipid Association has conducted a survey to better understand the diagnosis and treatment of patients with homozygous familial hypercholesterolemia (HoFH)…go to activity»